FAT BURNERS
-
Hardcore Fat Burners for Hardcore Bodybuilders -
we could as many companies do list dozens of so called FAT BURNERS that are
little more than high potency caffeine pills! Instead of which if the you are
looking for RESULTS = FAT LOSS then the best solution in terms of pure excess
body fat loss is EPHALEAN MAX STRENGTH FAT LOSS Capsules.
FAT BURNERS
EXTREME
FAT BURNING = Superior Weight
Loss with PRO SERIES T3 T4 BOOSTING THERMOGENIC - this Enhanced Formula Body Fat Burner.
HARDCORE EPHALEAN HARDCORE is designed and
developed utilising the highest quality Thermogenic ingredients to enhance
& boost FAT BURNING EXCESS WEIGHT LOSS. This Formula which
is ideal for both Men & Women is a MAX STRENGTH Solution to your
Body Fat Loss
requirements. Burn Away the Fat & see the old or New you underneath!
HARDCORE FAT STRIPPER PRO
SERIES WEIGHT LOSS TABLETS
- maximum
potency hardcore fat burners designed to maximise
weight loss. A potent combination of tried and tested ingredients in a powerful
stacker capsule that can maximise your body weight reduction goals:
THYROID T3 METABOLISM
Booster
BURN AWAY EXCESS POUNDS &
INCHES
REGULATE BLOOD SUGAR
REDUCE BODY FAT
LOWER CHOLESTEROL LEVELS
SUPPRESS APPETITE
INCREASE ENERGY LEVELS
SERIOUS FAT LOSS FOR
MEN & WOMEN - FULL STRENGTH FORMULA
HARDCORE EPHALEAN Hardcore - the ultimate weight loss fat
burning stacker tablets for MAXIMUM EXCESS WEIGHT
REDUCTION in the shortest space
of time. Proven ingredients in a potent stacker capsule for MAXIMUM EFFECT:
HARDCORE HARDCORE EPHALEAN
x 2 SPECIAL DEAL ORDER NOW only
£
Quantity:
TWO BOTTLES FOR THE PRICE
OF ONE - MEGA DEAL
This is a FULL STRENGTH
MAXIMUM WEIGHT REDUCTION formulation based on a combination of tried and tested
ingredients to
ensure maximum body fat reduction
If however you have more than 30 Pounds of Excess Body Fat that you
want to shift QUICKLY and you have been struggling for a long time to lose
weight the you need the ULTIMATE HARDCORE FAT LOSS COMBO.
EPHELEAN
MAX STRENGTH FAT BURNERS PLUS COLON CLEANSE BODY DETOX CAPSULES! Sometimes your
body is so full of chemicals from eating processed food, smoking or drinking
alcohol that the ingredients in the fat burners cannot do their job to their
maximum effect. If you are over 35 and have struggled with dieting or other
weight loss programs than this is the best solution for you. Clean out your
system from the inside so that EPHELEAN can do its FAT REDUCING job to MAXIMUM
EFFECT.
EXTREME FAT LOSS COMBO
HARDCORE EPHALEAN CAPSULES-
TWO BOTTLES FOR THE PRICE OF ONE = 2 x 60
PLUS
COLON CLEANSE DETOX 60 CAPULES
HARDCORE HARDCORE EPHALEAN
x 2 + COLON DETOX SPECIAL DEAL ORDER NOW only
£
Quantity:
TWO BOTTLES FOR THE PRICE
OF ONE - + COLON DETOX CAPSULESMEGA DEAL
WARNING - this is a FULL
STRENGTH FORMULATION ONLY FOR PEOPLE NEEDING TO LOSE EXCESS BODY FAT FAST
Ephelean contains FULL STRENGTH MAX POTENCY INGREDIENTS
- designed to strip away excess body fat as well as,
increasing T3 thyroid function, and increasing fat-burning activity..
One of the key ingredients is Chromium Polynicotinate
which has been shown in research studies to
facilitates and/or stimulates the metabolism of sugar, fat and cholesterol in
the body, as well as the function of insulin. Major hospital and
university studies have suggested that supplementation with chromium will
reduce body fat,
help build lean body muscle,
regulate blood
sugar and lower elevated cholesterol.
TARRYTOWN, NY -- June 23, 1998 -- Results of a double-blind, placebo
controlled clinical study showed that chromium aids in the loss of body fat,
without causing a loss in lean body mass. In the study, the 122 moderately
overweight individuals who took chromium lost an average of 6.2 pounds of body
fat as opposed to only 3.4 pounds in those individuals in the placebo group ~
that's 82% more
FAT LOSS!!!!!
Also included in this potent stacker capsule
is 5-Hydroxy-L-Tryptophan - 5 HTP in various studies has
been shown to
boost weight lossand improve sleep patterns. Research suggests that good serotonin levels reduces
appetite thereby assisting in weight loss. Serotonin is converted into melatonin
in the pineal gland and melatonin, in turn, regulates sleep cycles. As 5 HTP
increases serotonin levels it is able to improve sleep and aid in weight loss.
5-HTP can help curb appetite and lead to weight loss. Numerous people have
experienced a decrease in appetite from using 5-HTP. 5-HTP helped overweight
individuals adhere to dietary recommendations . A twelve week study was divided
into two six-week periods. For the first six weeks, there were no dietary
recommendations; for the second six weeks the women were placed on a
1,200-calorie diet. As shown in Table 1, the women who took the placebo lost
2.28 pounds, while the
women who took
the 5-HTP lost 10.34 pounds. 5-HTP appeared to promote weight loss
by promoting satiety-the feeling of satisfaction-leading to fewer calories being
consumed at meals. Every woman who took the 5-HTP reported early satiety.
Another key ingredient is L-Carnitine -
L-Carnitine in a study of 18 overweight subjects, carnitine greatly increased
weight loss. The subjects were split into two groups of 9. For 12 weeks, both
groups ate a healthy diet and performed moderate exercise. One group was given
2000 mg of carnitine, and the other a placebo. In the placebo group, the average
weight loss after 12 weeks was one pound. In the carnitine group, weight loss
averaged 11 pounds. Thats
11X MORE weight loss, simply by increasing
carnitine levels. Body fat percentage levels also decreased markedly in the
carnitine group.
LOSE EXCESS POUNDS FASTER
Caffeine Anahydrous has been
shown to
enhance fat-loss,
maximize energy, increase performance in aerobic and anaerobic events, and works
in synergy with other substances such as l-carnitine
Piper Nigrum has been shown in several clinical studies with healthy volunteers
in the U.S to boost gastrointestinal absorption of
nutrients, as measured by amounts present in the blood when administered
with Piper Nigrum as compared to the control group receiving the nutrient alone.
INCREASES THE EFFECTIVENESS OF THE FORMULA
So if you want to LOSE EXCESS BODY FAT FAST then this
HARDCORE FORMULATION will help you reach your ideal
body shape goals FASTER THAN THROUGH DIET & EXERCISE alone. In fact if you have
been dieting and exercising and not getting the results you want then HARDCORE
EPHALEAN is
just the product you have been looking for!
**WARNING** this is a hardcore formulation designed for use by Adults 18+ only
in order to complete the fat loss process you MUST drink at least 3 litres of
water every day in order to flush out the fat forming toxins.
So get slimmer & leaner FASTER with HARDCORE HARDCORE EPHALEAN now!!!
THIS IS A FULL STRENGTH FORMULA DESIGNED TO ACCELERATE THE STRIPPING AWAY OF
EXCESS LAYERS OF BODY FAT - ONLY USE IF YOU ARE SERIOUS ABOUT FAT LOSS - If you
only want to lose a couple of pounds then just this is not for you.
The Science of T3
Fat Loss
Thyroid Hormone or
T3 aids in fat loss - The primary way in which T3 promotes fat loss, is by
raising metabolism - T3 predominantly works by increasing levels of uncoupling
proteins (UCP's) that uncouple ATP synthesis from mitochondrial oxidation.
The first site of action is obviously UCP1, which leads to an increase in
thermogenesis. There are two other UCP's, namely UCP2 and UCP3. UCP2 is most
widely expressed, and UCP3 - The role of UCP3 is however not quite clear, as it
plays no role in thermogenesis (9), bringing into question whether or not it is
really an uncoupling protein. Another method in which T3 increases fat loss is
via its metabolite T2. T2 acts directly on the mitochondria to increase their
productive ability and thus producing extra ATP. T2 increases the need for
oxygen, so you take up more oxygen which leads to increased cardiovascular
pressure to transport all that oxygen to where it is needed (11).
Closely related to the substrate cycling is the effect T3 has on BAR's. During
long term stimulation by ligands, such as NE, phosphorylation and deactivation
of the B1AR and B2AR can occur, leading to reduced lipolysis in WAT. T3 can
increase the expression of BAR's (13) and increase your beta-adrenergic
capacity.
T3's effects on insulin and insulin sensitivity - seems to promote adipogenisis,
not only via re-esterification of fatty acids, but also through increased
sensitivity to insulin (14,15) . It is therefore wise to couple the manipulation
of T3 to the manipulation of insulin sensitivity.
However, hyperthyroid states generally lead to a reduction of insulin release
(17), due to increased apoptosis of the pancreatic beta-cells (18).
T3 is also a Phosphodiesterase inhibitor (21) since T3 can reduce PDE somewhat,
NE down regulates its own negative feedback by increasing T3 levels initially.
This same study showed that T3 can prevent Ca2+ dependent proteolysis and
possibly spare muscle mass on a diet. This is however highly conflicting
information, since T3 is only up regulated at the beginning of a diet, when you
are less likely to lose muscle and of course the fact that T3 itself can exert a
negative influence on muscle mass retention, since it initiates
ubiquitin-proteasome related catabolism (13). T3 also seems to increase Growth
Hormone levels (22).
Dressel U, Allen
TL, Pippal JB, Rohde PR, Lau P, Muscat GE. The peroxisome proliferator-activated
receptor beta/delta agonist, GW501516, regulates the expression of genes
involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol
Endocrinol. 2003 Dec;17(12):2477-93. Epub 2003 Oct 02.
Peters JM, Aoyama
T, Burns AM, Gonzalez FJ. Bezafibrate is a dual ligand for PPARalpha and
PPARbeta: studies using null mice. Biochim Biophys Acta. 2003 Jun
10;1632(1-3):80-9.
Kim MJ, Deplewski
D, Ciletti N, Michel S, Reichert U, Rosenfield RL. Limited cooperation between
peroxisome proliferator-activated receptors and retinoid X receptor agonists in
sebocyte growth and development. Mol Genet Metab. 2001 Nov;74(3):362-9.
Axelrod L, Ryan
CA, Shaw JL, Kieffer JD, Ausiello DA. Prostacyclin production by isolated rat
adipocytes: evidence for cyclic adenosine 3',5'-monophosphate-dependent and
independent mechanisms and for a selective effect of insulin. Endocrinology.
1986 Nov;119(5):2233-9.
Hatae T, Wada M,
Yokoyama C, Shimonishi M, Tanabe T. Prostacyclin-dependent apoptosis mediated by
PPAR delta. J Biol Chem. 2001 Dec 7;276(49):46260-7.
Rasmusson AM,
Southwick SM, Hauger RL, Charney DS. Plasma neuropeptide Y (NPY) increases in
humans in response to the alpha 2 antagonist yohimbine. Neuropsychopharmacology.
1998 Jul;19(1):95-8.
Sarkar S, Lechan
RM. Central administration of neuropeptide Y reduces alpha-melanocyte-stimulating
hormone-induced cyclic adenosine 5'-monophosphate response element binding
protein (CREB) phosphorylation in pro-thyrotropin-releasing hormone neurons and
increases CREB phosphorylation in corticotropin-releasing hormone neurons in the
hypothalamic paraventricular nucleus. Endocrinology. 2003 Jan;144(1):281-91.
Astrup A,
Lundsgaard C, Madsen J, Christensen NJ. Enhanced thermogenic responsiveness
during chronic ephedrine treatment in man. Am J Clin Nutr. 1985 Jul;42(1):83-94.
Teruel T,
Hernandez R, Benito M, Lorenzo M. Rosiglitazone and retinoic acid induce
uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent
manner in fetal primary brown adipocytes. J Biol Chem. 2003 Jan 3;278(1):263-9.
Epub 2002 Oct 31.
Vidal-Puig A,
Solanes G, Grujic D, Flier JS, Lowell BB. UCP3: an uncoupling protein homologue
expressed preferentially and abundantly in skeletal muscle and brown adipose
tissue. Biochem Biophys Res Commun. 1997 Jun 9;235(1):79-82.
Lanni A, Moreno M,
Lombardi A, de Lange P, Goglia F. Control of energy metabolism by iodothyronines.
J Endocrinol Invest. 2001 Dec;24(11):897-913.
Ma SW, Foster DO.
Redox state of brown adipose tissue as a possible determinant of its blood flow.
Can J Physiol Pharmacol 62: 949-956, 1984
Clement K,
Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh
GS, Langin D. In vivo regulation of human skeletal muscle gene expression by
thyroid hormone. Genome Res. 2002 Feb;12(2):281-91.
Torrance CJ,
Devente JE, Jones JP, Dohm GL. Effects of thyroid hormone on GLUT4 glucose
transporter gene expression and NIDDM in rats. Endocrinology. 1997
Mar;138(3):1204-14
Romero R, Casanova
B, Pulido N, Suarez AI, Rodriguez E, Rovira A. Stimulation of glucose transport
by thyroid hormone in 3T3-L1 adipocytes: increased abundance of GLUT1 and GLUT4
glucose transporter proteins. J Endocrinol. 2000 Feb;164(2):187-95.
el Hadri K,
Pairault J, Feve B. Triiodothyronine regulates beta 3-adrenoceptor expression in
3T3-F442A differentiating adipocytes. Eur J Biochem. 1996 Jul 15;239(2):519-25.
Fukuchi M,
Shimabukuro M, Shimajiri Y, Oshiro Y, Higa M, Akamine H, Komiya I, Takasu N.
Evidence for a deficient pancreatic beta-cell response in a rat model of
hyperthyroidism. Life Sci. 2002 Jul 19;71(9):1059-70.
Jorns A, Tiedge M,
Lenzen S. Thyroxine induces pancreatic beta cell apoptosis in rats. Diabetologia.
2002 Jun;45(6):851-5. Epub 2002 May 17.
Viguerie N, Millet
L, Avizou S, Vidal H, Larrouy D, Langin D. Regulation of human adipocyte gene
expression by thyroid hormone. J Clin Endocrinol Metab. 2002 Feb;87(2):630-4.
Richelsen B,
Sorensen NS. Alpha 2- and beta-adrenergic receptor binding and action in gluteal
adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism.
1987 Nov;36(11):1031-9.
Navegantes LC,
Resano NM, Migliorini RH, Kettelhut IC. Catecholamines inhibit Ca(2+)-dependent
proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP. Am J
Physiol Endocrinol Metab. 2001 Sep;281(3):E449-54.
Volpato CB, Nunes
MT. Role of thyroid hormone in the control of growth hormone gene expression.
Braz J Med Biol Res. 1994 May;27(5):1269-72.
Warnings: This product is an extremely powerful dietary supplement intended for
use by healthy adults between 18-50 years of age only. Not for use by
individuals under the age of 18 years. Do not use this product if you are
pregnant, nursing, prone to dehydration, or exposed to excessive heat.
References:
1. Stanko RT, Tietze DL, and Arch JE. Body composition, energy utilization, and
nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate.
Am J Clin Nutr 1992;56(4):63035.
2. Stanko RT, Reynolds HR, Hoyson R, et al. Pyruvate supplementation of a
low-cholesterol, low-fat diet: Effects on plasma lipid concentration and body
composition in hyperlipidemic patients. Am J Clin Nutr 1994;59:42327.
3. Ivy JL, Cortez MY, Chandler RM, et al. Effects of pyruvate on the metabolism
and insulin resistance of obese Zucker rats. Am J Clin Nutr 1994;59:33137.
4. Stanko RT, Robertson RJ, Galbreath RW, et al. Enhanced leg exercise endurance
with a high-carbohydrate diet and dihyroxyacetone and pyruvate. J Appl Phys
1990;69(5):165156.
5. Stanko RT, Robertson RJ, Spina RJ, et al. Enhancement of arm exercise
endurance capacity with dihydroxyacetone and pyruvate. J Appl Phys
1990;68(1):11924.
6. Deboer LWV, Bekx PA, Han L, et al. Pyruvate enhances recovery of rat hearts
after ischemia and reperfusion by preventing free radical generation. Am J
Physiol 1993;265:H157176.
7. Cicalese L, Subbotin V, Rastellini C, et al. Acute rejection of small bowel
allografts in rats: Protection afforded by pyruvate. Trans Proc 1996;28(5):2474.
8. Cicalese L, Lee K, Schraut W, et al. Pyruvate prevents ischemia-reperfusion
mucosal injury of rat small intestine. Am J Surg 1996;171:97101.
9. Stanko RT, Mullick P, Clarke MR, et al. Pyruvate inhibits growth of mammary
adenocarcinoma 13762 in rats. Cancer Res 1994;54:10041007.
10. Carreau JP. Biosynthesis of lipoic acid via unsaturated fatty acids. Methods
Enzymol. 1979;62:152-158. (PubMed)
11. Reed LJ. A trail of research from lipoic acid to alpha-keto acid
dehydrogenase complexes. J Biol Chem. 2001;276(42):38329-38336. (PubMed)
12. Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a
potential therapy for chronic diseases associated with oxidative stress. Curr
Med Chem. 2004;11(9):1135-1146. (PubMed)
13. Kramer K, Packer L. R-alpha-lipoic acid. In: Kramer K, Hoppe P, Packer L,
eds. Nutraceuticals in Health and Disease Prevention. New York: Marcel Dekker,
Inc.; 2001:129-164.
14. Cicchillo RM, Iwig DF, Jones AD, et al. Lipoyl synthase requires two
equivalents of S-adenosyl-L-methionine to synthesize one equivalent of lipoic
acid. Biochemistry. 2004;43(21):6378-6386.(PubMed)
15. Zhao X, Miller JR, Jiang Y, Marletta MA, Cronan JE. Assembly of the covalent
linkage between lipoic acid and its cognate enzymes. Chem Biol.
2003;10(12):1293-1302. (PubMed)
16. Cicchillo RM, Booker SJ. Mechanistic investigations of lipoic acid
biosynthesis in Escherichia coli: both sulfur atoms in lipoic acid are
contributed by the same lipoyl synthase polypeptide. J Am Chem Soc.
2005;127(9):2860-2861. (PubMed)
17. Miller JR, Busby RW, Jordan SW, et al. Escherichia coli LipA is a lipoyl
synthase: in vitro biosynthesis of lipoylated pyruvate dehydrogenase complex
from octanoyl-acyl carrier protein. Biochemistry. 2000;39(49):15166-15178. (PubMed)
18. The Role of the Carnitine System in Human Metabolism Department of Internal
Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
19 . Carnitine in Type 2 Diabetes Istituto di Medicina Interna, Catholic
University, Roma, Italy
20 . Effects of Carnitine on Thyroid Hormone Action Cattedra di Endocrinologia,
University of Messina School of Medicine, Messina, Italy